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ABSTRACT 
 
Using Spatial Visualization Software to Influence Cancer Control Policy:  
A Case Study of Prostate Cancer in South Carolina 
by 
Shannon Amelia Shropshire 
Prostate Cancer in the United States shows great disparities among race and socioeconomic 
status. Disparities in cancer rates in South Carolina are severe. Cancer control policies are 
lacking in ways to identify reasons for high risk populations and cost-effective ways to do so. An 
innovative spatial visualization program called the GeoViz Toolkit was used to determine areas 
of high Prostate Cancer incidence and mortality in South Carolina (rates obtained from the South 
Carolina Central Cancer Registry) compared with socioeconomic variables (education, income, 
lack of health insurance, and living in rural areas) and race. From there, recommendations were 
made using the South Carolina Cancer Alliance’s “South Carolina Comprehensive Cancer 
Control Plan” objectives for Prostate Cancer for the top counties that were determined to have 
the highest need of intervention. These 11 counties include Colleton, Hampton, Allendale, 
Barnwell, Fairfield, Dillon, Marion, Marlboro, Williamsburg, Bamberg, and Orangeburg.   
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CHAPTER 1 
 
INTRODUCTION 
 
 Prostate Cancer (PrCa) in the United States shows great disparities among race and 
socioeconomic status. Disparities in cancer rates in South Carolina are severe (Drake et al., 
2006). Cancer control policies are lacking in ways to identify reasons for high risk populations 
and cost-effective ways to do so. The use of new technologies will help to optimize cancer 
control policy decisions with limited resources and in effect help to address the differences in 
socioeconomic variables (Bezold, 2006). Growing and adapting to the problems and solutions in 
the world is a crucial part of Public Health and is necessary to continue to serve the general 
population. New technologies are a way of shifting with the times.  
 The GeoViz Toolkit is an exploratory spatial data visualization software program mostly 
designed by Frank Hardisty at Penn State University. Others authored certain parts of the 
program, their names and contributions can be found at http://code.google.com/p/geoviz/ 
wiki/GeoVizToolkitContributors. It is an application version of the GeoVista Studio found at 
http://www.geovista.psu.edu/geoviztoolkit/main.html. Continuous development of the program 
was funded through grant monies from the Centers for Disease Control and Prevention (CDC). 
The initial intent of the program design was to compare the strengths and weaknesses of spatial 
statistical methods for use by state-based Comprehensive Cancer Control (CCC) programs (CDC 
Cooperative Agreement Funding Opportunities, n.d.). The program contains a plethora of 
applications that can be used to analyze data including but not limited to histograms, scatter 
plots, geomaps, star plots, parallel plots, and the ability to use SaTScan within the program. 
SaTScan is another visualization tool that allows analysis of “spatial, temporal, and space-time 
scan statistics” (SaTScan, 2005). The data must be entered into a shapefile using GIS software in 
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order to upload the specific state map that allows for the analysis. The GeoViz Toolkit is 
freeware that is being continuously updated and improved and available online at 
http://www.geovista.psu.edu/grants/cdcesda/software/. 
 The mapping of epidemiologic data occurred at least as early as 1854 as John Snow 
mapped the deaths of the London Cholera epidemic (Friendly, 2006). Today, the National 
Cancer Institute provides data visualization resources on their website at 
http://gis.cancer.gov/resources/visualization.html. Spatial visualization software such as the 
GeoViz Toolkit can be used to help identify and therefore address disparities of PrCa in areas 
with high incidence and mortality, especially in those areas with late stage diagnoses (Seidman, 
2006). Identification of problem areas can lead cancer control programs to create specially 
defined interventions in areas that were potentially unnoticed prior to the capabilities of such 
software and many in the field recognize this advantage (Ghetian, Parrott, Volkman, & 
Lengerich, 2008). In the identified areas in higher need of intervention, cancer control policies 
can be implemented based on the socioeconomic variables that are lacking in that community. 
Identifying those variables is merely the first step to a healthier community.  
 According to the 2007 United Health Foundations state rankings, South Carolina rests at 
number 42, when number one is the healthiest state and number 50 is the unhealthiest. (United 
Health Foundation, 2008). In 2004, PrCa had the highest incidence rate of new cancer diagnoses 
in the state, 163.5 per 100,000 (Center for Disease Control and Prevention, 2007). This rate is 
higher than the United States average by 18.2. The PrCa mortality rate in South Carolina is the 
second highest (including cancers that kill both men and women) only behind Lung and 
Bronchus Cancer, and is also above the national average by 7.2 per 100,000 (Center for Disease 
Control and Prevention, 2007). CCC is a strong basis for combating cancer and the addition of 
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spatial visualization software will increase the ability to do so (Ghetian et al., 2008). Hopefully, 
the GeoViz Toolkit is the beginning of a new era and advisory committees around the country 
will take notice of the possibilities that this type of analysis and prevention plan identification 
and implementation could bring. 
 CCC is an emerging model for reducing cancer incidence, morbidity, and mortality 
through prevention, early detection, treatment, rehabilitation, and palliation in hopes of 
impacting the limited resources and achieving more desirable cancer prevention and control 
outcomes (Center for Disease Control and Prevention, 2003). South Carolina has created a 
Cancer Control Advisory Committee (SCCCAC) that is made up of South Carolinians who meet 
three times a year to attempt to better the outcomes of cancer rates in the state. The committee is 
made up of MDs, PhDs, MPHs, RNs, and others who serve the South Carolina health community 
in one way or another. There are also task forces within the SCCCAC that are working on 
specific cancers. The committee was created by South Carolina law and the members are 
appointed by the Department of Health and Environmental Control (DHEC) Commissioner 
(South Carolina Department of Health and Environmental Control, n.d.).  
 The importance of using new technologies such as the GeoViz Toolkit can only make a 
time consuming process shorter, allowing faster, smarter, more efficient decisions about cancer 
control policy. With quicker identification and more specialized interventions could come lower 
rates of disparities between different races as well as different socioeconomic variables.  
 Using the GeoMap, StarPlotMap, SingleScatterPlot, and StarPlot applications, among 
others, of the GeoViz Toolkit, determinations were made about which counties have a higher 
need for intervention. These decisions were based upon socioeconomic (SES) information and 
race combined with incidence, stage of diagnosis, and mortality rates. The color coded maps that 
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the GeoViz Toolkit produces give a quick, easily determinable visual response to the question of 
which counties have higher rates combined with whatever socioeconomic variable is being 
considered.  Figure 1 shows an example of the StarPlot tool. This example includes all races, 
age-adjusted prostate cancer rates for total incidence, early- and late-stage, and mortality data.  
 
 In Figure 1, Orangeburg is the county with the largest combined magnitude of all four of 
these variables. There are two ways of identifying the counties that would benefit most from an 
intervention. One, they are ranked from lowest to highest in this chart. When using the program, 
scrolling over each StarPlot reveals which county it is and what the rates are, shown where 
Orangeburg is in Figure 1. Another way to judge is simply by visualizing which county appears 
to have the largest StarPlot. This is more applicable in the StarPlotMap tool as seen in Figure 2. 
 
 
Figure 1. StarPlot with PrCa Rates 
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Results from the GeoViz Toolkit analysis can be used to examine specific counties and suggest 
plans to reduce incidence rates, especially late stage diagnoses and mortality rates.  
 A statistical program called SPSS (version 15.0) was also used to test for correlation 
values for the SES variables being used. This part of the process determined which 
socioeconomic variables or race were more likely associated with counties having higher rates of 
prostate cancer incidence and mortality. 
 All of this information combined was used to make recommendations for possible future 
steps in controlling PrCa in South Carolina. Some of the recommendations are based on the 
2005-2010 South Carolina Cancer Alliance Cancer Control Plan. Further recommendations are 
based on the results of this project.  
 
Figure 2. StarPlotMap with PrCa Rates and Urbana with African-American 
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 Pieces of this work have been presented at two different conferences. First, at the 
Tennessee Public Health Association’s Conference in October of 2007 and then at the Council of 
State and Territorial Epidemiologists Conference in June of 2008, both entitled “Visualizing 
Socioeconomic Determinants of Prostate Cancer.”  
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CHAPTER 2 
REVIEW OF THE LITERATURE 
Geographical Information Systems 
 Geographical information systems are an innovative way to enhance policy decisions. 
Rushton (2003) predicts that more and more studies will incorporate GIS science into health 
analyses. Public health has had a long history of cancer research and applying technological 
advancements (Ghetian et al., 2008). Abe, Martin, and Roche (2006) used SaTScan to determine 
areas of late stage PrCa in New Jersey adding that spatial analyses can increase ways to 
determine areas of less favorable outcomes. Other authors suggest using visualization as a way to 
determine patterns of incidence, late stage diagnoses, mortality, accessibility to care, spatio-
temporal patterns, poverty, and environmental exposures among other uses (Drake et al., 2006; 
Ghetian et al.; Marusek, Cockburn, Mills, & Ritz, 2006; Mather et al., 2006). Visualization in the 
context of public health refers to the ability to map the disease data obtained and actually being 
able to see where the areas of disparities are. Seeing where there are groups of counties with high 
rates can be invaluable.     
 Bell, Hoskins, Pickle, and Wartenberg (2006) warn against using inappropriate maps in 
presentations and making sure that the intended audience is capable of deciphering their 
meaning. The GeoViz Toolkit is a complicated program and the starplots application, while 
advantageous to the trained eye, may not initially make sense without a thorough explanation. 
However, when presenting to public health officials and others in the field, this should not be 
difficult. Brewer (2006) encourages using multiple maps in order to get the point across and 
states that informative legend wording, color choices, symbol types, and suitable map projections 
are keys to skilled mapmaking. Parrott, Hopfer, Ghetian, and Lengerich (2007) examined using 
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maps as a communication form and reviewed the 36 available CCC plans for the presence of 
maps. They found that only 14 state’s plans contained maps while 10 states had tools with which 
queries could be done to map cancer incidence and mortality. Stage at diagnosis was rarely 
available (Parrott et al.). Stage is one of the major dependent variables being considered in this 
study.  
 Bhowmick, Griffin, MacEachren, Kluhsman, and Lengerich (2008) assessed favorably 
the willingness of Public Health officials to use geospatial software, yet Ghetian et al. (2008) 
state that the use of GIS in cancer control efforts is unevenly employed. Many state CCC 
programs perceive a need for more training in GIS, and only half of the state CCC directors 
currently had access to geocoded data (Hopfer, Chadwick, Parrott, Ghetian, & Lengerich, 2008). 
The GeoViz Toolkit is an attempt by the CDC to get all of the CCC programs on the same page.  
 Anselin (2006) advises ways not to lie with spatial statistics. There are many limitations 
such as rare occurrences, counties with higher proportions of older men, etc. that depending on 
how they are analyzed can yield different results. “When it comes to policy, spatial statistical 
analyses are only a means, and not the end” (Anselin, p. 3). The author also talks about the 
continuously changing technological advances and how it is hard to determine best practices, but 
with clearinghouses and access to other experts through the internet many of these hurdles can be 
overcome. Sharing results through a Web portal was another idea to increase the understanding 
of GIS and the ability of colleagues to work together (MacEachren, Gahegan, & Pike, 2004).   
 Marusek et al. (2006) suggest that when looking at environmental exposures, taking into 
account complete residential histories is important. The data that are being used in this study, 
collected by the South Carolina Central Cancer Registry, only identify the person’s county of 
residence at the time of diagnosis. Granted this study is not looking at environmental exposures, 
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but Drake et al. (2006) did suggest that South Carolina would be a good place to do so due to the 
presence of soil selenium and cadmium concentrations, which affect prostate metabolism, in 
rural areas where more African Americans tend to live. Xiao, Gwede, Kiros, and Milla (2007) 
also analyzed environmental data and found racial and geographic disparities.  
 Several clusters of elevated risks of PrCa mortality were determined using a spatial scan 
statistic for 506 state economic areas (Jemal, Devesa, Kulldorff, Hayes, & Fraumeni, 2000). The 
largest risk for African-American (AA) men was in the South Atlantic area, but no 
socioeconomic characteristics could be attributed to this group and further study is suggested 
(Jemal, Kulldorff, Devesa, Hayes & Fraumeni, 2002). An in-depth look at several SES variables 
in South Carolina is part of this study.  
Prostate Cancer 
Screening 
 Much debate has occurred regarding PrCa screening. Inevitably, when there is a huge 
initial push for testing incidence rates rise drastically, and it is still uncertain whether mortality 
decreases with increased screening (Albertsen, 2005; Di Matteo & Di Matteo, 2005; Yasunaga, 
Ide, Imamura, & Ohe, 2006). Albertsen (2006) also questions whether or not PrCa should be a 
public health concern because many men diagnosed are unlikely to survive another 10 years due 
to age of diagnosis, suggesting that screening over a certain age is futile. While screening does 
not cause any harm, the treatment that follows a diagnosis does. The author cites the results of 
the Prostate Cancer Outcomes Study as a reason for physicians to caution their patients regarding 
changes in quality of life after treatment, where 60% were impotent and 8% were incontinent 
within 18 months of surgery (Albertsen, 2006).   
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 On a similar note, the United States Preventive Services Task Force issues 
recommendations regarding screening for different types of diseases. As of 2002, PrCa is rated 
an “I,” which means that there is not enough sufficient information for the Task Force to make a 
recommendation. Their rationale is as follows: 
“The USPSTF found good evidence that PSA screening can detect 
early-stage prostate cancer but mixed and inconclusive evidence 
that early detection improves health outcomes. Screening is 
associated with important harms, including frequent false-positive 
results and unnecessary anxiety, biopsies, and potential 
complications of treatment of some cancers that may never have 
affected a patient’s health. The USPSTF concludes that evidence is 
insufficient to determine whether the benefits outweigh the harms 
for a screened population” (Agency for Healthcare Research and 
Quality, 2002). 
  
 Ekwueme, Stroud, and Chen (2007) cite the cost of testing as a concern for public health 
officials due to limited resources and the uncertainty of the overall benefit. Krahn et al. (1994) 
analyzed the costs of three types of tests for PrCa and determined that screening asymptomatic 
men is not advisable because it may decrease health outcomes and increase the financial burden. 
Makinen et al. (2002) determined that men with relatives who have had PrCa did not have a 
higher risk of the disease and selective screening would have missed 94% of cancer cases in their 
study. Multiple risk factors must be considered along with areas of high prevalence when 
determining a solution. This is merely another example that there is no simple answer to 
formulating ways to economically screen.   
 Mariotto, Etzioni, Krapcho, and Feuer (2007) assessed the frequencies at which white 
and AA males began PSA testing when it first became available. They determined that older 
white males tested earlier as did younger AA males indicating similar patterns overall and 
concluded that racial factors were not a reason behind the differences in PrCa.  
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 In an attempt to access the willingness of a population to accept a cancer screening 
policy, Paul, Nicholls, Priest, and McGee (2008) surveyed a group of women in New Zealand 
about breast cancer. After being well informed about the disease, the screening process, and the 
costs, all but one woman voted against a governmental policy for screening. These results 
question how forceful policy makers should be regarding the health of the people they serve. 
Testing should be available to everyone who wants it, but information regarding the benefits and 
consequences are just as, if not more, important. Refusal of treatment to well-informed men is 
not an option, especially when they know the risk of potentially experiencing more harm that 
good (Schroder, 2005). Yasunaga et al. (2006) hypothesized that better education about the 
screening process would reduce the desire for testing. Health education will be strongly 
considered in the possibilities for interventions. 
 Phillips et al. (2004) considered the gatekeeper requirements of insurance policies and 
their association with screening use. While for several female cancers they found that 
gatekeepers were beneficial and increased screening rates, this was not the case for PrCa. The 
authors do encourage policy makers to consider the gatekeeper when making public health 
decisions.  
 Rogerson, Sinha, and Han (2006) analyzed spatial-temporal tends in PrCa mortality and 
suggest that declines in Florida and Southern California may be due to realized beneficial results 
of screening programs. Obviously, there is still much dissent between whether or not widespread 
screening is advantageous or not.       
Incidence  
 As previously stated, a rise in PrCa screening will increase the incidence rates (Albertsen 
et al., 2005). While incidence data are certainly important, this study initially put much more 
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emphasis on mortality and late-stage diagnosis. This is because all men who live long enough 
will have some elevated level of prostate-specific antigen (Bostwick et al, 2004). Higher PrCa 
incidence is not necessarily associated with higher risk factors and poorer outcomes (Gilligan, 
2005).     
Mortality 
 The National Cancer Institute estimates that in 2008, 28,660 men will die from PrCa 
(National Cancer Institute, n.d.). In South Carolina, the 2008 estimate of new cases of PrCa is 
2,520 and over 400 deaths (American Cancer Society, 2008). Jemal et al. (2000) found PrCa 
mortality to be elevated in the Southeast region. PrCa mortality should be a high priority, and in 
this study it will be considered as one of the main dependent variables. Higher mortality is 
associated with lower SES (Vinnakota & Lam, 2006), while incidence rates are not similarly 
associated (Gilligan, 2005). Higher mortality rates are also associated with being AA (Davey 
Smith, Neaton, Wentworth, Stamler, & Stamler, 1998; Godley et al., 2003; Howard, Anderson, 
Russell, Howard, & Burke, 2000). Access to health care can also affect the survival likelihood 
(Greenwald & Henke, 1992). 
Costs  
 Chang et al. (2004) estimated the costs of cancer from national surveys and federal 
databases for 1999-2000. The costs for seven cancers, which include direct and indirect, were 
estimated by these authors to be $60.9 billion and $15.5 billion respectively (Chang et al.). In 
California, Max et al. (1998) estimated the direct costs and costs of lost productivity due to 
premature death only from PrCa to both equal $180 million; therefore, the total being $360 
million for 1998 alone. Prostate cancer’s mean monthly costs were $2,187 (Chang et al.). 
Yabroff, Warren, and Brown (2007) found that costs were generally higher in the first year after 
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diagnosis and the last year of life. In 2001, Benoit, Gronberg, and Naslund attempted to estimate 
the cost per year of life saved with various types of screening and for different age groups. For 
PSA screening alone, for men aged 50-70, the cost was $3822-$4956 per year. Using both PSA 
and DRE screening for men aged 50-59 the cost was less at $2339-$3005 (Benoit et al.). 
Ekwueme et al. (2007) estimated the resource costs of screening, including physician’s time, 
patients time away from work, and laboratory costs. For PSA screening, the cost in the U.S. was 
more than in other industrialized countries at a value of $37.23, but DRE screening was less than 
in other industrialized countries and valued at $31.77 (Ekwueme et al.). “Society must decide if 
the years of life saved in these men warrants the use of its limited health care resources” (Benoit 
& Naslund, 1997a, p. 1533).  
 There is much debate about whether or not PrCa screening is cost effective or not; Benoit 
et al. (2001) claim that it is. However, in a previous article by two of the same authors, they warn 
that men aged 50-70 may not reap the benefits of screening till they are in their 80s (Benoit & 
Naslund, 1997b). Krahn et al. (1994) found that screening with PSA did increase life expectancy 
but decreased quality-adjusted life expectancy and do not recommend screening asymptomatic 
men as all programs increase costs.  
Treatment 
 Treatment of earlier stages of PrCa is more expensive than treatment of later stages 
(Benoit & Naslund, 1997b). Godley et al. (2003) considered AA versus white survival rates 
regarding three different types of treatments: (1) surgery, (2) radiation therapy, and (3) 
nonaggressive treatment. African-American patients had a lesser median survival time than 
whites for each type of treatment: 1.8 years less for surgery, .7 of a year less for radiation 
therapy, and 1 year less for nonaggressive treatment (Godley et al., 2003). Greenwald and Henke 
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(1992) compared treatment based on fee for service providers and health maintenance 
organizations. Over a 20-year period considered by Hall, Holman, Wisniewski, and Semmens 
(2005) in a study done in Australia, radical prostatectomy increased from 3.1% to 20.1%, while 
non-radical treatment including transurethral, open or closed prostatectomy decreased by half. 
Treatment outcomes are an important part of any cancer screening process; however, this study 
does not include data regarding such outcomes. 
Stage 
 Areas with large concentrations of late stage diagnoses are particularly important due to 
the lesser survival rates (Abe et al., 2006). Conlisk, Lengerich, Demark-Wahnefried, Schildkraut, 
and Aldrich (1999) state that, for diagnoses of PrCa, stage is one of the most determining factors 
of mortality. They found income and health insurance status to be inversely correlated with a late 
stage diagnosis for AA males, but not for whites (Conlisk et al.). Jemal et al. (2005) found 
correlations between late-stage incidence and mortality in both white and AA males (r=.38 and 
r=.53 respectively). Du et al. (2006) determined that survival of either stage was largely 
determined by SES. African-American men tend to be diagnosed at later stages of PrCa (Sarma 
et al., 2006). While both early and late stage data were received for this study, only late 
(regional/distant) stage will be a primary concern and a dependent variable.  
Socioeconomic Status 
 Socioeconomic status has many variables. The following are the topics that were found to 
be most valuable in the evaluation of PrCa within other literature. Lower SES is associated with 
early mortality (Du et al. 2006; Howard et al., 2000).  
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Education 
 Several authors cite being less educated as a possible risk for higher mortality in PrCa 
(Abe et al., 2006; Albano et al., 2007; Ndubuisi, Kofie, Andoh, & Schwartz, 1995; Talcott et al., 
2007; Vinnakota & Lam, 2006). Albano et al. found that AA men with less than a high school 
education were twice as likely to die from PrCa as AA men with more than a high school 
education. Dale, Vijayakumar, Lawlor, and Merrell (1996) reviewed 21 studies regarding PrCa 
and socioeconomic variables and suggest that at least income and education should be used. This 
study will consider educational levels as an independent variable at less than a high school 
education compared to those with more than a high school education.    
Income 
 The poverty level as defined by the Census bureau in 2000 was $17,050 for the 48 
contiguous states for a family of four (U.S. Department of Health and Human Services, 2000). 
Persons who live in poverty are more likely to have higher rates of mortality (Abe et al., 2006). 
Winkleby and Cubbin (2003) found that cancer mortality was higher for those with lower 
incomes across gender and the six racial and ethnic groups they studied. Bradley, Given, and 
Roberts (2001) concluded that if cancer control programs continue to advance, focus areas 
should include early detection for the poor. Wilkinson, List, Sinner, Dai, and Chodak (2003) 
assessed if education about PrCa would change the awareness of African American men in 
Illinois; higher income was associated with higher scores both before and after. Many authors 
used income as a determinant of SES along with several other factors in regards to PrCa (Dale et 
al., 1996; Davey Smith et al., 1998; Di Matteo & Di Matteo, 2005; Freeman, Durazo-Arvizu, 
Arozullah, & Keys, 2003; Gilligan, Wang, Levin, Kantoff, & Avorn, 2004; Howard et al., 2000; 
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Kim, Eby, & Piette, 2005; Ndubuisi et al., 1995; Talcott et al., 2007). This study will consider 
persons below the poverty line, and persons within 150% of the poverty line.     
Access 
 Persons living in more rural counties face a lack of health care services such as hospital 
closings and less rural health departments and are more likely not to have health insurance 
(Drake et al., 2006). Access also influenced the type of treatment received. Greenwald and 
Henke (1992) found that “HMO patients were less likely to receive surgery but more likely to 
receive radiation therapy than those in fee-for service settings” (p. 1099). Hall et al. (2005) found 
that being admitted to a rural hospital in Australia increased the 3-year mortality rate and a lack 
of health care insurance increased that possibility.   
 Jemal et al. (2005) assessed access to medical care based on the incidence of late-stage 
disease. The authors conclude that “10% to 30% of the geographic variation in mortality rates 
may relate to variations in access to medical care” (p. 590). The disparity between those with 
health insurance coverage and those without, or those without a usual source of care physician is 
growing (Swan, Breen, Coates, Rimer, & Lee, 2003). McDavid, Tucker, Sloggett, and Coleman. 
(2003) found a 15% difference in three year relative survival based on those privately insured 
versus the uninsured. Access in this study will be measured by a lack of health insurance. 
Rural 
 Much of South Carolina’s African American population resides in rural areas of the state, 
where they are more likely to live in poverty, report lower health status, and be lacking in health 
insurance coverage (Drake et al., 2006). Hall et al. (2005) considered several factors including 
geographical effects on 3-year survival in Australia. They found that those admitted to rural 
hospitals had a higher 3-year mortality rate than those admitted to urban hospitals (Hall et al.). 
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Non-metro counties were found to have greater levels of late-stage diagnosis as well as mortality 
(Jemal et al., 2005). From 1950-2000, mortality rates were higher in rural counties in the 
Northern Plain states when considering crop patterns and PrCa (Rusiecki, Kulldorff, Nuckols, 
Song, & Ward, 2006). Whether an area is urban or rural will be taken into consideration during 
this study. 
Age 
 The nature of PrCa is that any man who lives long enough is likely to have an increased 
level of prostate-specific antigen (PSA). Freeman et al. (2003) looked at comparisons between 
Veterans Affairs (VA) and private sector health systems and determined that only in the private 
sector was age an increased risk for mortality. Gilligan et al. (2004) considered racial screening 
rates in the elderly, determining that AA Medicare recipients were noticeably less likely to 
undergo screening. Mariotto et al. (2007) found similar results for white males over age 60. 
Powell, Schwartz, and Hussain (1995) determined that for men in the VA system survival rates 
for whites were greater for those under age 70, but AA men over age 70 were more likely to have 
lower mortality. Annual income, age, and hospitalization history were likely to increase the 
willingness to pay for PrCa screening in Japanese men aged 40-59 (Yasunaga et al., 2006).   
 Many studies controlled for age (Albano et al., 2007; Davey Smith et al., 1998; Delfino 
Ferrini, Taylor, Howe, & Anton-Culver, 1998; Du et al., 2006; Kim et al., 2005; Krieger et al., 
1999; Mather et al., 2006). Because the rates considered in this study are age-adjusted, age will 
not be one of the independent variables being taken into account for this study.  
Race 
 “Understanding the causes of the high prostate cancer mortality seen among black men 
remains the major challenge in the area of social disparities and prostate cancer” (Gilligan, 2005, 
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p. 45). Racial disparities are always a subject of concern in public health, especially within 
diseases where a certain race consistently has higher rates. South Carolina PrCa rates fall into 
this category. African-American men routinely are diagnosed at later stages of disease, have 
higher rates of overall incidence, and higher rates of mortality (Gilligan; Godley et al., 2003; 
Jemal et al., 2006; Ndubuisi et al., 1995; Powell et al., 1995; Sarma et al., 2006; Talcott et al., 
2007). Jemal et al. (2002) found that for AA men there was a cluster of higher PrCa rates in the 
South Atlantic area.  
 In the District of Columbia, AA patients are younger and their tumors appear to be more 
aggressive (Ndubuisi et al., 1995). However, Powell et al. (1995) found a crossover effect; AA 
men over age 70 appear to have higher survival rates. 
 In a study done by Bradley, Clement, and Lin (2008), AA men were less likely to receive 
surgery. Cohen et al. (2006) established that AA men had a 13-month less disease-free survival 
time than whites. In the same study, Asian men had the longest disease-free survival time, 26 
months longer than whites, with Hispanic men having the second longest at 16 months (Cohen et 
al.). Godley et al. (2003) also found that AA men had lower median survival times after 
treatment as well.   
 Conlisk et al. (1999) found health insurance and income to be inversely correlated with 
stage in AA men, but these factors were not associated with white men. Dale et al. (1996) could 
not conclude that racial differences between AAs and whites were based solely on race or if SES 
factors were more responsible. Davey Smith et al. (1998) studied the differences in risk factors 
for AAs and whites.  When they controlled for income, the differences were greatly reduced, and 
other adjustments did not alter the risk. Howard et al. (2000) found that SES accounted for much 
of the earlier mortality for AA men; however, this was not the case for PrCa.   
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 Men who have family members with a previous history of PrCa are more likely to have 
the disease themselves. Drake, Lathan, Okechukwu, and Bennett (2008) found that AA men in 
South Carolina who have a family history are not more likely to be tested. Gilligan et al. (2004) 
determined that AA race is a strong predictor of whether or not elderly men have PSA screening 
tests. Mariotto et al. (2007) used a model simulation to attempt to explain racial adoption of PSA 
testing. According to their results, testing did not make a major difference in the mortality rates 
and declines. However, by their own admission, retrospective data sources have their limitations 
(Mariotto et al.). 
 Sarma et al. (2006) looked at AA men’s PrCa and the relationship with sexual behavior 
and sexually transmitted diseases. They found that men who reportedly had 25 or more partners 
were 2.8 times more likely to get cancer than men who had had fewer than five partners (Sarma 
et al.). “African American men acknowledged their greater risk of Prostate Cancer, accepted 
greater responsibility for their health and reported more personal failures that delayed diagnosis” 
(Talcott et al., 2007, p. 1599).       
Health Policy 
 Policy is an important part of addressing health disparities. Understanding the risk factors 
of PrCa can have a direct impact on policy (Bostwick et al., 2004). There is also an inverse 
relationship where policy has an impact. The National Cancer Institute is an example, where 
there is a Congressional mandate for public dissemination of health information (Croker et al., 
2004). Cancer control managers recognize the policy implications that come with the ability to 
map PrCa and know the need for updated applications (Ghetian et al., 2008).       
 Dobrow, Goel, Lemieux-Charles, and Black (2006) examined how policy makers in 
Ontario used evidence-based decision making and concluded that the challenge was to link broad 
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interpretations of evidence to the appropriate policy questions, all the while keeping in mind the 
policy objectives. Drake et al. (2006) stress using community-based participatory research in 
advancing health policy and suggest that perhaps the current PrCa screening material is not 
appropriate for the South Carolina population. The same authors also mention that in South 
Carolina unequal weight is given to breast and cervical cancer screening, where no extra funding 
is provided by law to PrCa screening (Drake et al., 2006).  
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CHAPTER 3 
METHODS 
There were several methods used for this study. Certain research questions were explored 
based upon county level variables of socioeconomic status and race compared with incidence 
and mortality data for PrCa in South Carolina. This chapter explains the variables, where they 
were obtained, the software package used, the South Carolina Cancer Control Plan, how the data 
were analyzed, and how confidentiality was maintained.  
Research Questions 
1. How do the independent variables affect the dependent variables? 
2. How do the dependent variables vary with each other? 
Independent Variables 
 The independent variables used to answer the research questions of this study are based 
on reviews of the literature as well as variables that were accessible. These variables include: 
education, income, health insurance, rural areas, screening rates, infant mortality rates and race. 
See Appendix A for how the variables are coded.  
 The variable used to address education is a percentage of persons over the age of 24, 
residing in a county who have less than a high school education. Two income variables were 
used. One is the percentage of persons living in a county under the poverty line. In 2000, the 
midline for the years the data was collected, the poverty line was $8,350 for one person (U.S. 
Department of Health and Human Services, 2008). The second variable used is the percentage of 
persons living within 150% of the poverty line. Health insurance is an indicator of access to 
health care. In this study it is the percentage of persons living in a county without health 
insurance.  
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 The variable used to assess the extent to which a county is considered rural is called 
URBANA. This variable will be different from the others because low areas of this variable will 
be more telling than high areas like the rest of the variables. Because AA men have some of the 
highest incidence and mortality rates of PrCa, the race variable is the percentage of persons 
residing in a county who are AA.  
Dependent Variables 
 While all incidence rates will be considered, the two main dependent variables will be the 
age-adjusted rate per county of men diagnosed with late-stage PrCa and the age-adjusted PrCa 
mortality rate per county. The other two incidence rates are: age-adjusted rates of early-state 
PrCa and age-adjusted total incidence rates. Race-specific variables will also be considered for 
both AA and white.    
Data 
 The cancer data, from 1997-2003, were obtained from the South Carolina Central Cancer 
Registry. These include: county level incidence rates for PrCa, both early and late stage, county 
level mortality rates for PrCa, and incidence and mortality rates for all types of cancer at the 
county level. The South Carolina Central Cancer Registry (SCCCR) collects data from hospitals 
on all types of cancer. The SCCCR was created in 1996 and has since been nationally recognized 
several times as a gold level rating through the North American Association of Central Cancer 
Registries and the Centers for Disease Control and Prevention (Vena, 2006, p. 175). 
 The SES variables including: LTHSEDA, PLTCPOVA, PLTCVPOVA, URBANA, and 
BLACK, as well as others not used in this evaluation, were obtained through a previous project 
with Penn State University. They were assembled from the County Attributes file from the 
SEER*Stat program which is calculated using the 2000 Census.  
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 Health insurance coverage percentages and Medicare enrollment percentages were 
obtained at the county level from the South Carolina Community Profiles webpage at 
http://www.sccommunityprofiles.org/index.asp. This website is sponsored by the United Way of 
South Carolina, the South Carolina Budget and Control Board, and the Sisters of Charity 
Foundation of South Carolina. The data on this website focus on demographic and economic 
data from the U.S. Census at the state, county, zipcode, and census tract levels. 
 PrCa Screening rates for 2001 were retrieved from the South Carolina Department of 
Health and Environmental Control website under their Behavioral Risk Factor Surveillance 
System data at http://www.scdhec.gov/hs/epidata/BRFSS/psatest.html. One issue with these rates 
is that they are only listed by region. Therefore, depending on the size of the region, up to seven 
counties will have the same percentage of screening rates. Another issue with these rates is the 
small number of persons surveyed. For this question, only 689 men responded to the survey 
(South Carolina Department of Health and Environmental Control, 2003). 
 Infant mortality rates were obtained from the South Carolina Department of Health and 
Environmental Control’s website from a report entitled “Infant Mortality and Selected Birth 
Characteristics: 2001 South Carolina Residence Data” for the 1999-2001 rates. These rates are 
calculated for three years since they are more stable and more representative than one single 
year. However, rates were also considered for only the year 2000 obtained from the same 
website in a report similarly titled only for 2000 instead of 2001.       
The GeoViz Toolkit Applications 
 The GeoViz Toolkit has numerous applications. Only a few tools, VariablePicker, 
SpreadSheetBean, StarPlot, ParallelPlot, GeoMap, StarPlotMap, and SingleScatterPlot, were 
used in this study. To analyze the previous research questions the key variables were input into a 
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shapefile and then uploaded into the GeoViz Toolkit. A shapefile can be created with GIS 
software such as ArcGis. They are saved as a collection of files that must all be present to be 
usable, six in this case. Shapefiles store geographic and attribute information (U.S. Geological 
Survey, 2008).  
 VariablePicker, StarPlot, GeoMap, and StarPlotMap are default settings and immediately 
show on the screen when the shapefile is loaded. VariablePicker shows all of the variables that 
are included in the uploaded shapefile. The user selects the variables to be considered and hits 
send selection. The SpreadSheetBean allows the user to see not only all of the variables input but 
the actual values as if in a spread sheet. StarPlot is a visualization tool where each variable 
selected is represented proportionally within the circle. The lines extending from the center of 
each circle represents a different variable. For example, Allendale County is highlighted in 
Figure 3 and has the highest percentages of all South Carolina Counties of no health insurance, 
less than a high school education, people living below the poverty line, and people who live in 
the county who are AA.  
 
Figure 3. StarPlot with Independent Variables 
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Figure 4. ParallelPlot with Independent Variables 
 
Figure 5. StarPlotMap with Independent Variables 
 
 
Because each variable is proportionately represented in the StarPlot, four of five of the lines in 
the Allendale County StarPlot are touching the outside of the circle. This is interpreted to mean 
that for those four variables Allendale County has the highest percentages of all 46 counties.   
 The ParallelPlot tool is similar only showing from smallest to largest within each 
variable. Figure 4 is an example. As the user scrolls across the lines, the county is highlighted. 
Again, Allendale County is the example. 
 The GeoMap is a bivariate map that allows the user to visualize areas that have high rates 
in two areas being considered shown in Figure 5. The user may choose the colors being used. 
These can be seen in the data 
analysis section.  The StarPlotMap 
is a combination of the StarPlot tool 
and the GeoMap tool. In Figure 5, 
the colors on the map represent 
PrCa incidence rates compared with 
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mortality rates. The areas that are more darkly shaded are the areas that have high rates of both. 
The StarPlots overlap the county whose information they represent. The variables are the same 
as those represented above. 
 The SingleScatterPlot function can be used to determine correlation as well as provide a 
visualization to easily determine outliers. Figure 6 shows that age-adjusted all cancer mortality is 
positively associated with infant mortality rates for 1999-2000.  
 Several of the other functions of the GeoViz Toolkit include a variable transformer, 
histograms, link graphs, an animator, Moran’s map and the ability to incorporate SaTScan, along 
with others, but these were not used in this analysis.  
South Carolina Comprehensive Cancer Control Plan 
An assessment was made as to which counties have the greatest need regarding public 
health intervention. Once these areas were determined, recommendations were made, based on 
 
Figure 6. SingleScatterPlot with Infant Mortality Rates and Cancer Mortality 
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the SC Cancer Control Plan objectives for 2005-2010 and previous research presented in the 
literature, in order to help decrease the disparities. 
 The South Carolina Cancer Alliance created a Cancer Control Plan for 2005-2010 based 
on the 2004 Cancer Report Card (South Carolina Department of Health and Environmental 
Control, 2004). There are three objectives within the plan pertaining to PrCa, Objectives four and 
five under the Health Disparities section and Early Detection subsection, and Objective 3 under 
the Advocacy and Policy section. The recommendations that follow in this study are based on 
these objectives and the strategies that follow in Figure 7 and Figure 8.    
Early Detection: 
 
Figure 7. SCCA Cancer Plan, October 2005, p. 26 
Advocacy and Policy:  
 
Figure 8. SCCA Cancer Plan, October 2005, p. 35 
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Data Analysis 
 Each of the independent variables was examined compared to each dependent variable 
using SPSS to determine correlation values (two-tailed) and statistical significance, p-values of 
less than .05. Each independent variable was also examined compared with each dependent 
variable in the GeoViz Toolkit. The GeoViz Toolkit offers the user several ways of looking at 
the same thing. Which component is used depends on the user’s point of view and analytical 
ability to see things. The counties with the highest rates of both variables were determined per 
research question using standard deviation for all except the rural versus urban question, in 
which case quartiles were used. An overall comparison of all independent variables and 
dependent variables was completed using the GeoViz Toolkit and determinations were made 
based on the StatPlotMap tool about which counties were in the most need of help. 
Confidentiality 
 Persons whose information was obtained for this study remain anonymous. The data 
collected from the SCCCR are on an individual level, but rates are suppressed under a certain 
number in order to prevent any possibility of determining who has a certain disease. In this 
study, all of the information is at a county level and there is no possibility of identifying 
individuals. 
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CHAPTER 4 
RESULTS 
 Each independent variable was considered compared with each dependent variable. 
Using the GeoMap tool in the GeoViz Toolkit, maps were created to show which counties have 
high rates of both variables being considered. Correlations were calculated for all variables. The 
StarPlot tool was used to compare all of the independent variables together and the StarPlot Map 
was used to compare all of the independent variables with incidence and mortality.   
Maps 
 All of the maps in this section were made using the GeoViz Toolkit. For the bivariate 
maps the colors used are red and blue. The higher the rates of both of the variables being 
considered the darker the color will be. Choosing to use red and blue will therefore make the 
areas of highest concern purple. Two standard deviations are used as the distributing factor. 
Some variables have to be considered differently due to the nature of the variable, but the maps 
follow the previously stated format unless otherwise noted. 
Correlations 
 Using SPSS to determine the correlation values and test for significance shows that none 
of the SES variables are statistically significant when it comes to predicting early- or late-stage 
incidence at the time of diagnosis. Counties with high percentages of AAs are positively 
correlated with early- and late-stage incidence, but only early-stage incidence is significant at a p 
value of .028. It is the closest to being statistically significant when relating to late-stage 
diagnoses, but that is only at a p value of .059. On the other hand, every variable being 
considered is significant in predicting mortality rates. 
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 The correlation values are shown in Table 1 for early and late stage diagnosis, total 
incidence, as well as mortality. 
 Table 1. 
 
Correlation Values 
N=46  Early-Stage 
Incidence 
Late-Stage 
Incidence 
Total 
Incidence 
Mortality 
Less Than a 
HS Education 
Pearson 
Correlation -.097 .099 -.006 .458(*) 
 Significance .522 .514 .971 .001 
Income Below 
the Poverty 
Line 
Pearson 
Correlation .261 .231 .362(*) .640(*) 
 Significance .080 .123 .013 .000 
No Health 
Insurance 
Pearson 
Correlation .165 .096 .340(*) .622(*) 
 Significance .272 .526 .021 .000 
Urban Pearson 
Correlation -.229 -.021 -.164 -.316(*) 
 Significance .126 .888 .277 .032 
African-
American 
Pearson 
Correlation .323(*) .280 .403(*) .728(*) 
 Significance .028 .059 .006 .000 
* indicates statistical significance at a value of p<.05 
 
Education and Incidence 
 Less than a high school education does not appear to be a very good predictor of 
incidence. For late-stage diagnoses it is positively correlated, but only at .099 and not significant 
at p=.514. For early-stage incidence and total incidence it is actually negatively correlated, 
showing that persons with more education are diagnosed sooner, but neither of those values are 
significant. Overall incidence is the least significant of all the variables being considered at a 
correlation value of -.006, and a p value of .971. Basically, it shows no correlation at all as can 
be seen by the almost horizontal line in Figure 9. 
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Figure 9. SingleScatterPlot with Education and Total Incidence Rates 
 Figure 10 shows the counties with late stage diagnosis and high rates of persons with less 
than a high school education in purple.  
 
 
 
 
 
 
 
 
 
 Figure 10. Late-Stage Incidence Rates with Education 
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The counties shown in Figure 10 are Cherokee, Union, Chester, Fairfield, Laurens, Abbeville, 
McCormick, Lee, Marion, Williamsburg, Jasper, Colleton, Bamberg, Barnwell, and Allendale. 
Maps for early-stage diagnosis and total incidence can be found in Figures 28 and 29 in 
Appendix B.  
Poverty and Incidence 
 Late-stage diagnosis is also correlated with persons below the poverty level; however, it 
is not significant for early or late stage. Total incidence is highly correlated and at a statistically 
significant level. Figure 11 shows total incidence with persons living below the poverty line.  
 
Figure 11. Total Incidence Rates with Poverty 
Fairfield, Marlboro, Dillon, Williamsburg, Georgetown, Orangeburg, Barnwell, Bamberg, 
Allendale, Hampton, and Colleton counties have the higher rates. Early- and late-state incidence 
rates compared with poverty can be found in Appendix B in Figures 30 and 31.  
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Health Insurance and Incidence 
 The lack of health insurance is not a very positive predictor of late stage incidence at a 
correlation value of .096. Neither stage is statistically significant with values of .272 and .526 
respectively. Overall incidence and a lack of health insurance are significant at a correlation 
value of .340 and a p value of .021.  
 Barnwell, Bamberg, Orangeburg, Colleton, Allendale, Hampton, Williamsburg, 
Georgetown, Dillon, and Marlboro are the counties highlighted in Figure 12 that have high rates 
of both high total incidence rates and high rates of no health insurance. Early- and late-stage 
incidence rates with health insurance can be found in Figures 32 and 33 in Appendix B.  
 
Figure 12. Total Incidence Rates with Health Insurance 
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Rural Versus Urban and Incidence 
 Persons living in counties that are more rural than urban are more likely to be diagnosed 
with PrCa. However, no correlation value is significant for this variable: overall incidence, early- 
or late-stages. Late-stage incidence considered with the urban variable has the second lowest 
correlation value of any of the variables considered and listed in Table 1 with a predictive value 
of -.021, therefore, also with the second highest p value making this comparison extremely 
insignificant. 
 Figure 13 is different than the other maps due to the nature of this variable. In this case, 
counties that are the darkest blue with no shades of red are the important ones. 
 
Figure 13. Total Incidence Rates with Rural Versus Urban 
This variable measures the percent of urban population per county, while the percent of rural 
population is what is being considered in this research question. This map is also different in that 
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it is measured in quartiles rather than by standard deviation because we are looking at the 
opposite of the variable input into the GeoViz Toolkit. Fairfield and Williamsburg are the only 
two for total incidence. Early- and late-stage with health insurance can be found in Appendix B 
in Figures 34 and 35. 
African-American and Incidence 
 Figure 14 is a bivariate map of early-stage incidence of PrCa and the percentage of AA 
persons per county. The darker purple counties are areas of concern and are highlighted here as 
Fairfield, Chester, Richland, Darlington, Sumter, Florence, Dillon, Williamsburg, Georgetown, 
Orangeburg, Barnwell, Allendale, Hampton, Colleton, and Bamberg Counties. Total incidence 
rates and late-stage rates with percentage of AA persons per county can be found in Appendix B 
in Figures 36 and 37 respectively.  
 
Figure 14. Early-Stage Incidence Rates with African-American 
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Education and Mortality 
 Persons having less than a high school education are at a higher risk of PrCa mortality. 
The correlation value is .458 and having less education is a significant predictor of PrCa 
mortality with a p value of .001. The counties highlighted are Laurens, McCormick, Saluda, 
Fairfield, Marlboro, Dillon, Marion, Darlington, Lee, Clarendon, Williamsburg, Jasper, 
Hampton, Colleton, Bamberg, Barnwell, and Allendale. Figure 15 shows less than a high school 
education and PrCa mortality.  
 
Figure 15. Mortality Rates with Education 
Poverty and Mortality 
 McCormick, Fairfield, Lee, Darlington, Marion, Dillon, Marlboro, Williamsburg, 
Clarendon, Orangeburg, Bamberg, Allendale, Barnwell, Colleton, Jasper, and Hampton 
 are the counties shown in Figure 16. 
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Figure 16. Mortality Rates with Poverty 
Living below the poverty line is the second most highly correlated value in Table 1 with a value 
of .640. The statistical significance is .000 indicating the highest level of significance. Living 
within 150% of the poverty line is also positively correlated with increased PrCa mortality at a 
value of .670. The map for living within 150% of the poverty line is in Appendix B and shows 
the same counties in the darkest purple except Sumter County is also highlighted in Figure 38.  
Health Insurance and Mortality 
 A lack of health insurance is a positive predictor for PrCa mortality at a value of .622. It 
is statistically significant, where the p value is .000. The counties shown in Figure 17 are Lee, 
Marion, Williamsburg, Allendale, Saluda, Darlington, Marlboro, Dillon, Clarendon, Orangeburg, 
Bamberg, Barnwell, Colleton, Jasper, and Hampton. 
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Figure 17. Mortality Rates with Health Insurance 
Rural Versus Urban and Mortality 
 Persons living in urban areas are less likely to have higher rates of PrCa mortality. The 
negative value of -.316 indicates that counties that are more rural have a higher likelihood of 
PrCa mortality. The p value is significant at .032. 
 Lee, Fairfield, Saluda, McCormick, Clarendon, and Williamsburg are the brightest blue 
counties on the map in Figure 18 and represent those with high PrCa mortality and low rates of 
urbanization, therefore, being those that are most rural. The shading on this map is also shown in 
quartiles rather than standard deviation.  
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Figure 18. Mortality Rates with Rural Versus Urban 
African-American and Mortality 
 Counties that have high percentages of AA persons have the highest predictive value of 
having high rates of PrCa mortality at a value of .728. Of all of the variables considered, this is 
the most predictive in Table 1. Figure 19 shows a scatterplot representing these values. 
 
Figure 19. SingleScatterPlot with Mortality Rates and African-American 
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 There are 17 counties represented in Figure 20, the largest number of any of the maps 
considered. The counties shown are Jasper, Hampton, Colleton, Allendale, Barnwell, Bamberg, 
Orangeburg, Williamsburg, Clarendon, Sumter, Lee, Darlington, Marion, Dillon, Marlboro, 
Fairfield, and McCormick. 
 
Figure 20. Mortality Rates with African-American 
White Variables Only 
 Of the five independent variables considered earlier (education, poverty, health 
insurance, rural versus urban, and African-American), only two can be broken down into white 
only. However, all of the dependent variables are available for white only comparison. Table 2 
shows the correlation values along with their p values for significance. No value is significant 
and therefore none of these correlation values are worth considering.  
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Table 2. 
 
White Correlation Values 
N=46  Early Stage 
Incidence 
Late Stage 
Incidence 
Total 
Incidence 
Mortality+ 
Less Than a 
HS Education 
Pearson 
Correlation -.174 -.071 -.127 .055 
 Significance .246 .638 .400 .714 
Income Below 
the Poverty 
Line 
Pearson 
Correlation -.019 .006 -.004 .082 
 Significance .902 .970 .977 .589 
* indicates statistical significance at a value of p<.05 
+indicates missing values were replaced with the state average 
 
See Appendix B for the maps for white only comparison in Figures 39-46.  
Less Than a High School Education  
 For white total incidence rates there are four fewer counties highlighted than the 11 
highlighted in race-adjusted incidence rates, and only five are the same. One noticeable 
difference is that three of the white counties highlighted are in Appalachia; two of those do not 
show up in the race-adjusted rates. The early-stage rate maps are extremely similar except the 
white map has one more county than the race-adjusted and two counties are in Appalachia. The 
white late-stage map is quite noticeably focused in the Appalachian region and its surrounding 
counties. Only six counties are highlighted for white mortality as opposed to 16 for the race-
adjusted counties. Two of the six are not on the overall map; they are Cherokee and Anderson, 
both Appalachian counties.   
Income Below the Poverty Line  
 When considering total incidence, the white rates only have six counties highlighted and 
three of them are in Appalachia. The other three are also highlighted on the race-adjusted map. 
The race-adjusted map has a total of 11 counties highlighted. For early-stage white incidence, 
there are 10 counties highlighted versus the 11 highlighted on the race-adjusted. Again, four of 
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the seven white late-stage counties are in Appalachia or touching an Appalachian county, not the 
case for the race-adjusted rates. For white mortality there are only six counties as opposed to 16 
for race-adjusted mortality. Five of the six white mortality highlighted counties are also on the 
race-adjusted map, but one is different and that’s Cherokee.   
African-American Variables Only 
 As with the white only variables, only education and poverty can be considered for the 
independent variables and all of the incidence and mortality variables are available. Table 3 
shows the correlation values along with the significant p values. Maps can be found in Appendix 
B in Figures 47-54. 
Table 3. 
 
African-American Correlation Values 
N=46  Early-Stage 
Incidence 
Late-Stage 
Incidence 
Total 
Incidence 
Mortality+ 
Less Than a 
HS Education 
Pearson 
Correlation -.381(*) -.312(*) -.338(*) .182 
 Significance .009 .035 .022 .226 
Income Below 
the Poverty 
Line 
Pearson 
Correlation -.053 -.026 -.075 .004 
 Significance .725 .863 .621 .979 
* indicates statistical significance at a value of p<.05 
+indicates missing values were replaced with the state average 
 
 Less Than a High School Education 
 All three incidence rates are significantly negatively correlated with having less than a 
high school education. Therefore, the more education AA people have the more likely they are to 
be diagnosed with PrCa, or more likely this means that people with more education and being 
screened more often. The maps are available in Appendix B. Laurens is the only county, out of 
nine, that is highlighted on the AA early-stage incidence map that is not on the race-adjusted 
map, while Georgetown is the only highlighted county, of 10, on the AA late-stage incidence 
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map that is not on the race-adjusted map. Georgetown, Lancaster, and Laurens appear of the AA 
total incidence map and not on the race-adjusted incidence map. The other seven are the same. 
For AA mortality, it is positively correlated with having less than a high school education, but it 
is not significant. Chester and Lancaster are the only two counties not on the race-adjusted 
mortality map that are on the AA mortality map.  
Income Below the Poverty Line  
 Living below the poverty line is actually negatively correlated with all types of incidence 
and the positive correlation with mortality may as well be zero because it is so small. However, 
living below the poverty line is significantly correlated with having less than a high school 
education. Florence and Horry are not on the race-adjusted map, but the rest of the highlighted 
counties are for total incidence. Of the nine counties listed on the AA early-stage incidence map, 
Charleston and Florence are the only two not on the race-adjusted map. For AA late-stage 
incidence, Horry is the only difference. Of the six counties, Saluda is the only one highlighted on 
the AA mortality map that is not on the race-adjusted map.   
Screening Rates Compared to Mortality 
 Keeping in mind that screening rates have a low N value, and that they are only by 
region, it is hard to put a lot of validity into the answer to this question. However,  
the blue counties have high mortality and low screening rates, which are McCormick and Saluda. 
The red county has low mortality and high screening rates which is Beaufort. Figure 21 shows 
screening results from 2001. The results are not significantly correlated. Union, Lancaster, and 
Oconee join Beaufort as counties with high screening rates and low mortality for 2002 (See 
Figure 55 in Appendix B).  
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Figure 21. Mortality Rates with 2001 Screening Rates 
Incidence Compared with Mortality 
 Thirteen counties have high rates of total incidence as well as high rates of mortality. 
Total incidence and mortality are positively correlated at a value of .329 and are significant 
because p=.026. These counties, Hampton, Allendale, Barnwell, Bamberg, Colleton, Dorchester, 
Berkeley, Williamsburg, Orangeburg, Sumter, Marion, Dillon, and Fairfield, are highlighted in 
Figure 22. Early-stage is significantly positively correlated with mortality at a value of .305 
(p=.039). However, late-stage is not significantly correlated, but it is positively. Early- and late-
stage maps can be seen in Appendix B (Figures 56 and 57). 
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Figure 22. Mortality Rates with Late-Stage Incidence Rates 
Early-Stage Rates and Late-Stage Rates 
 Counties that have early-stage rates are likely to have late-stage rates. The two are 
significantly positively correlated at a value of .543 and a p value of .000. Sixteen counties have 
both early- and late-stage rates at a high level, as seen in Figure 23. They include Greenville, 
Abbeville, Chester, Fairfield, Richland, Marion, Georgetown, Williamsburg, Charleston, 
Dorchester, Berkeley, Orangeburg, Colleton, Allendale, Bamberg, and Barnwell. 
 
Figure 23. Early-Stage Incidence Rates with Late-Stage Incidence Rates 
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All Independent Variables 
 Using the StarPlot application can help to determine which counties have high rates of all 
of the independent variables. It would appear that Allendale County has the highest rates of four 
of the variables excluding URBANA in Figure 24. The counties that have high percentages of all 
of the variables are Dillon, Lee, Jasper, and Williamsburg. URBANA is not included in the 
StarPlot but assessed in the color. Therefore, counties that are white and the lighter shades of 
purple are the more rural counties.  
 
Figure 24. StarPlot with Independent Variables 
All Independent Variables with Incidence and Mortality 
 URBANA is represented in yellow in this map. The counties that have high rates of all of 
the independent variables as well as of the high total incidence and mortality are Barnwell, 
Fairfield, and Williamsburg in the most rural locations. Hampton, Colleton, Dillon, and 
Orangeburg follow in the second most rural quartile as shown in Figure 25.    
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Figure 25. StarPlotMap with Incidence and Mortality with Independent Variables 
Consistent Counties 
 Table 4 shows how many times each county showed up on a map.  
Table 4. 
 
Map Appearances 
County Early-stage 
Incidence 
Late-stage  
Incidence 
Total 
Incidence 
Mortality Total Sig. 
Cherokee  E  E  2  
Union  E    1  
Chester E B  E B  E B   6 1 
Fairfield E P B R  E P B R  E P B R  E P B R  16 7 
Laurens  E   E 2 1 
Abbeville E E    2  
McCormick  E P B   E P B  6 4 
Lee  E P H B  E P H B R  9 6 
Marion E H B  E P H B   E P H B  11 7 
Williamsburg E P H B R  E P H B  E P H B R  E P H B R  19 9 
Jasper  E P H B   E P H B 8 5 
Colleton E P H B  E P H B  E P H B  E P H B  16 8 
Bamberg E P H B  E P H B  E P H B  E P H B  16 8 
Barnwell  E P H B  E P H B R  E P H B  E P H B  17 8 
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Table 4 (cont). 
 
Map Appearances 
County Early-stage 
Incidence 
Late-stage 
Incidence 
Total 
Incidence 
Mortality Total Sig. 
Allendale E P H B  E P H B  E P H B  E P H B  16 8 
Darlington E P H B    E P H B  8 5 
Dillon E P H B   E P H B  E P H B  12 8 
Marlboro P   E P H B  E P H B  9 8 
Hampton   E P H B  E P H B 8 8 
Saluda    E H R  3 3 
Clarendon    E P H B R 5 5 
Orangeburg P H B  P H B  P H B   P H B  12 7 
Georgetown P H B  P H B  P H B    9 4 
Sumter B   B  B 3 3 
Richland B  B    2 1 
Florence B    B   2 2 
E is for Less Than a High School Education, P is for Living Below the Poverty Line, H is for 
No Health Insurance, B is for Black, and R is for Rural 
 
 Williamsburg appeared on the most maps with a total of 19. Barnwell was the second 
highest with 17, followed by four counties that had 16 which were Allendale, Bamberg, 
Colleton, and Fairfield. The next closest set of counties totals 12, four less.  
 When only considering counties where the correlation value was significant the total is 
nine maps and Williamsburg County is the only one to appear on all nine. Seven counties appear 
on eight maps which are Colleton, Bamberg, Barnwell, Allendale, Dillon, Marlboro, and 
Hampton. Orangeburg, Marion, and Fairfield counties each appear on seven of the nine maps.  
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Figure 26. Consistent Counties 
CHAPTER 5 
DISCUSSION 
 Attacking PrCa is complicated due to so many uncertainties of the disease. Is screening 
asymptomatic men effective? Does it do more harm than good? Yet, as previously mentioned 
PrCa is the second leading cancer killer of men in South Carolina (Center for Disease Control 
and Prevention, 2007). The following are recommendations based on the findings of this study as 
to possible areas of increased need of PrCa intervention. 
Consistent Counties 
 While analyzing all of the independent variables, compared with the dependent variables, 
20 maps were created. The number of times that each county appeared on one of these maps was 
totaled to use as a comparison for which counties are in the greatest need of an intervention. 
Williamson County appeared on 19 of the 20 maps. Barnwell County appeared the second 
highest number of times totaling 17. Four other counties appeared 16 times each, Allendale, 
Bamberg, Colleton, and Fairfield. The next closest number was only 12; therefore, these were 
not considered to be of the highest priority for this classification and not included on the map in 
Figure 26. Of the six counties that 
showed up on most of the maps, 
they are in five different regional 
health districts. This does not make 
a plan for implementing an 
intervention by district very easy. 
However, collaboration through 
some of the counties could 
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Figure 27. Correlation Consistent Counties 
increase the possibility because four of the six counties are situated in the same area and are all 
connected to each other. 
Correlations 
 The correlation values in Table 1 did reflect, for the most part, what this author thought 
as well as previous literature. However, the values were not nearly as high as expected and only 
nine of the 20 analyses were statistically significant at p<.05. Due to this fact, and only 
considering the significantly correlated values, only nine of the maps are taken into 
consideration, when previously the total possible of appearing on maps was 20. This would take 
into account all five independent variables compared with mortality, total incidence compared 
with less than a high school education, no health insurance, and a high percent of AA people per 
county, and AA compared with early-stage incidence. If this is the case, Williamsburg still has 
the highest total with all nine. However, the number of counties in need does increase from six to 
11 that have high numbers of appearances that are grouped together. The counties that are added 
that did not appear before were Dillon, Marlboro, Hampton, Orangeburg, and Marion, showing a 
greater need for some type of intervention in the southern area of the state. Figure 27 shows how 
there are two counties that are of 
concern, Fairfield and Williamsburg 
that are not with any of the other 
counties. This is also true of regional 
health districts. Fairfield and 
Williamsburg are the only ones that 
are in their district. Marlboro, Dillon, 
and Marion are all in the same region, 
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the Pee Dee region, and perhaps focusing a plan at the regional level could be beneficial and the 
same personnel could work on one project. The six counties that are located in the southern part 
of the state reside in three different districts. If the decision was made to plan for interventions at 
the regional level some resource allocation could occur because all 11 of the counties are in six 
regions, rather than having to budget for all 13 regions. This could cut down on more than half 
the costs or more funding could go to the areas in greater need. 
African-American Versus White 
 When considering AA rates versus white rates, the main difference is that higher white 
rates are associated with Appalachian counties. However, in those counties the AA rates are still 
higher than the white rates. Once again, this shows a need to focus on counties with higher rates 
of AA men because they are more likely to be affected by PrCa. The AA incidence rates are 
significantly negatively correlated with having less than a high school education (p=.009, .035, 
and .022 respectively for early-stage, late-stage, and total incidence rates). This indicates that AA 
men who are more educated are the ones being screened. Focusing in areas where there are low 
screening rates and high rates of AA people with less than a high school education would be one 
way to plan an intervention. Figure 58 highlights four counties (Abbeville, Chesterfield, Saluda, 
and McCormick), three of which are in the same district (See Appendix B). While screening 
rates are calculated by region, this author advises putting more educational emphasis with 
regards to PrCa screening into the Upper Savannah region than into any of the others because 
this is the area where the lowest screening rates occur and have the highest rates of AA persons 
with less than a high school education. The Upper Savannah region includes Abbeville, 
Edgefield, Greenwood, Laurens, McCormick, and Saluda counties.  
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Access Versus Screening 
 Bamberg County has high rates of no health insurance and low rates of screening. Using 
quartiles as the distributing factor, it is the only county in the lowest quartile for screening and 
the highest quartile for a lack of health insurance. While more than likely the need for increased 
health insurance will happen on a state-wide level, a county specific plan would be beneficial, 
especially because this county has high rates of all types of PrCa, early-stage, late-state, total 
incidence, and mortality. Therefore, men are being screened, but they are also dying. An increase 
in health insurance or access to treatment could decrease these rates.  
Late-Stage Incidence Versus Mortality 
 Areas with both high rates of late-stage incidence and high rates of mortality indicate an 
added need for intervention. The counties that have both are McCormick, Fairfield, Marion, 
Orangeburg, Colleton, and Bamberg. These areas are in greater need of screening. Once men 
have been diagnosed, those with lower incomes will need a means of treating their disease. This 
is where policymakers can help find ways of funding treatment. While policymakers did increase 
access to screening for breast and cervical, there is currently not a means for increased PrCa 
screening (Drake et al., 2006).  
Early Detection Objective 4 SCCA CA Plan 
 In order to increase the percent of diagnosis from 72.6% to at least 75% for early-stage 
diagnosis, increased screening activities should be focused on areas with higher rates of late-
stage diagnosis. Colleton County has the highest rates per 100,000 of late-stage incidence, yet it 
also has high rates of PrCa screening. Bamberg and Orangeburg also have high rates of late-stage 
incidence but are in the lowest quartile for screening. Attempting to increase screening in 
Bamberg and Orangeburg would be advisable first. However, increased screening will increase 
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incidence rates. Focusing on counties that have high mortality rates but low incidence rates could 
help to obtain this objective. These counties are Hampton, Jasper, Clarendon, Lee, Kershaw, 
Marlboro, Saluda, and McCormick.  
 Another way to look at obtaining this objective would be to focus in counties that have 
high rates of late-stage incidence but not high rates of early-stage incidence. These counties 
include Greenville, McCormick, Chester, Marion, Georgetown, and Barnwell. 
Early Detection Objective 5 SCCA CA Plan 
 The need to raise men’s awareness about PrCa screening is complicated. Focusing in 
areas where there are low screening rates and high rates of mortality is this author’s 
recommendation. These areas are McCormick County and Saluda County. They are the only two 
counties that are in the lowest quartile of screening rates and the highest quartile of PrCa 
mortality. Screening rates are, however, by regional health district. This indicates, once again, 
focusing in the Upper Savannah district. A comprehensive plan to educate men as to their need 
to know about what’s best for them and screening is imperative. The CDC created screening 
guides especially for AA men, perhaps putting those in locations that are easily accessible could 
be a start to education.       
Advocacy and Policy Objective 3 SCCA CA Plan 
 The strategy for this plan is at a state-wide level. The counties that have the highest rates 
of no health insurance are mostly those that also fall under the consistent counties discussed 
earlier and shown on the map in Figure 27 (See Appendix B). The consistent counties are those 
that show up on the maps again and again, no matter what variables are being considered. Breast 
and cervical cancer have had a successful plan that the state supported, but as previously 
mentioned, this could be expanded to other cancers and screening plans.  
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Challenges 
 Many challenges arise with a new program. First learning to use it will be difficult. 
Beyond that communicating and disseminating complicated disease information is always a 
complex process. However, time and experience will make it better and easier. Finding the right 
personnel to use and interpret the software could impede the process. The biggest challenge will 
be remembering that visualization software is a means of interpreting the data and not the only 
way (Anselin, 2006). 
Overall Recommendations 
 The first decision that policy makers have to make is what they plan to focus on. For 
instance, if they plan to make state-wide changes versus only focusing in areas of greater need or 
if they plan to focus on incidence, mortality, etc. Once this decision has been made, using the 
GeoViz Toolkit becomes easier because they will know what they are looking for. As previous 
authors have mentioned, using mapping software can show areas in higher need, but without 
direction, the effort can become futile. Recommendations have been made throughout this 
section as to possible focus areas, but the priority chosen by the policy makers will determine 
which counties to focus on and where resources should be spent.  
Benefits to Health Services Administration 
 Using the GeoViz Toolkit could help to reduce the cancer burden. Identifying those areas 
in need could increase the ability to allocate resources rather than having to disperse them all 
over the state and could focus funds into certain areas. Also, decreasing the prevalence of any 
disease would decrease the costs on the health care system. This program could be used for any 
cancer or other disease with the right data. PrCa is merely one example and only the beginning. 
This program also allows identification of areas that are lacking in certain resources, such as 
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mapping areas with low health insurance, low screening rates, etc. The benefits for policy 
makers follow along the same lines.    
Limitations of This Study 
 Several limitations of this study occurred throughout the progress. One limitation was the 
time of the author and obtaining information from persons in South Carolina with direct 
knowledge of the activities of the Prostate Cancer Task Force. Another limitation was access and 
permission to PrCa data on an individual level due to restrictions on confidentiality from both the 
IRB and the South Carolina Central Cancer Registries Policies. Therefore, having to use county 
level data does require making a lot of assumptions, such that it is actually the people who are 
getting PrCa that have low income, less than a high school education, are AA, live in rural areas, 
and do not have insurance.   
 As the GeoViz Toolkit is a work in progress, several problems occurred during its use. 
One of these problems was the inability of the scatterplot function to match the correlation 
values of SPSS. This could very well have been a user error, but this author was unable to 
determine the cause of the disagreement. Another issue was the inability to load the data. Not 
knowing or having a GIS program in which a shapefile could be created, the data always had to 
be sent to someone at the South Carolina Department of Health and Environmental Control 
office. While the shapefile was always returned in a timely fashion, the process no doubt slowed 
the results. An easier interface for uploading data would make the process of analysis easier. 
Future Recommendations 
 In future studies about PrCa in South Carolina, age should be considered. It was not a 
part of this study and the counties in need may vary due to where younger persons are being 
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diagnosed because PrCa will more than likely effect most men to some degree, if they live long 
enough.  
 Individual data could possibly produce more conclusive results. This study analyzed data 
at the county level. It is possible that the persons who die from PrCa are not the ones who have 
low income, are undereducated, etc. Even though it is highly unlikely based on previous 
literature, it would still produce more convincing evidence of a need for an intervention. 
However, an analysis similar to this one could be done, if this software were in the hands of 
people who have access to individual level data. 
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CHAPTER 6 
 
CONCLUSION 
 
 Spatial visualization is a useful tool for informing cancer control policy. Presenting 
complicated disease control information in any format is not easy. However, presenting 
information about a program that is new to many of the people is even more complicated. The 
GeoViz Toolkit is a complicated and not always user-friendly program, but with the right 
personnel and a little training, could be extremely useful for identifying areas of increased need 
of intervention. Comprehensive Cancer Control agencies would benefit fully from its use and, 
therefore, so could the populations in which the high disparities of PrCa incidence and mortality 
occur.   
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APPENDICES 
APPENDIX A 
  
Coded Variables 
Variable Coded As: 
Total PrCa Incidence from 1997-2003 R_ALL_97_03 
Early-stage PrCa Incidence from 1997-2003 R_ALL_EARLY 
Late-stage PrCaIncidence from 1997-2003 R_ALL_LATE 
PrCa Mortality from 1997-2003 AAPM 
Total Cancer Mortality 1997-2003 AAAM 
Less Than a High School Education 2000 LTHEDA 
Income Below the Poverty Line 2000 PLTCPOVA 
Income Within 150% of the Poverty Line 2000 PLTCVPOVA 
African-American Persons Living in a County 2000 BLACK 
Rural Versus Urban 2000 URBANA 
No Health Insurance 2000 HI 
White Less than a High School Education 2000 LTHEDW 
African-American Less than a High School Education 2000 LTHEDB 
White Income Below the Poverty Line 2000 PLTCPOVW 
White Income Within 150% of the Poverty Line 2000 PLTCVPOVW 
African-American Income Below the Poverty Line 2000 PLTCPOVB 
African-American Income Within 150% of the Poverty Line 2000 PLTCVPOVB 
PrCa Screening Rates 2001 PCSR01 
PrCa Screening Rates 2002 PCSR02 
Infant Mortality Rates 2000 IMR2000 
White Total PrCa Incidence from 1997-2003 R_W_97_03 
White Early-Stage PrCa Incidence from 1997-2003 R_W_EARLY 
White Late-Stage PrCa Incidence from 1997-2003 R_W_LATE 
White PrCa Mortality from 1997-2003 AAWPM_2 
African-American Total PrCa Incidence from 1997-2003 R_B_97_03 
African-American Early-stage PrCa Incidence from 1997-2003 R_B_EARLY 
African-American Late-stage PrCa Incidence from 1997-2003 R_B_LATE 
African-American PrCa Mortality from 1997-2003 AABPM_2 
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APPENDIX B 
 
Maps 
 
Figure 28. Early-Stage Incidence Rates with Education 
Counties highlighted: Barnwell, Allendale, Colleton, Bamberg, Williamsburg, Marion, Dillon, 
Darlington, Fairfield, Chester, and Abbeville 
 
Figure 29. Total Incidence Rates with Education 
Counties highlighted: Cherokee, Chester, Fairfield, Marlboro, Dillon, Williamsburg, Barnwell, 
Bamberg, Colleton, Allendale, and Hampton 
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Figure 30. Early-Stage Incidence Rates with Poverty  
Counties highlighted: Barnwell, Allendale, Bamberg, Colleton, Orangeburg, Fairfield, 
Darlington, Dillon, Marion, Williamsburg, and Georgetown 
 
Figure 31. Late-Stage Incidence Rates with Poverty 
Counties highlighted: McCormick, Fairfield, Lee, Marion, Georgetown, Williamsburg, 
Orangeburg, Bamberg, Colleton, Jasper, Allendale, and Barnwell 
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Figure 32. Early-Stage Incidence Rates with Health Insurance 
Counties highlighted: Allendale, Barnwell, Bamberg, Colleton, Orangeburg, Williamsburg, 
Georgetown, Marion, Dillon, and Darlington 
 
Figure 33. Late-Stage Incidence Rates with Health Insurance 
Counties highlighted: Jasper, Colleton, Allendale, Barnwell, Bamberg, Orangeburg, 
Williamsburg, Georgetown, Marion, and Lee 
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Figure 34. Early-Stage Incidence Rates with Rural Versus Urban 
Counties highlighted: Fairfield, and Williamsburg 
 
Figure 35. Late-Stage Incidence Rates with Rural Versus Urban 
Counties highlighted: Fairfield, McCormick, and Barnwell 
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Figure 36. Total Incidence Rates with African-American 
Counties highlighted: Orangeburg, Bamberg, Barnwell, Allendale, Hampton, Colleton, Sumter, 
Georgetown, Florence, Dillon, Marlboro, Chester Williamsburg, and Fairfield 
 
Figure 37. Late-Stage Incidence Rates with African-American 
Counties highlighted: McCormick, Jasper, Colleton, Allendale, Barnwell, Bamberg, Orangeburg, 
Richland, Fairfield, Chester, Lee, Marion, Williamsburg, and Georgetown 
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Figure 38. Mortality Rates with 150% of Poverty Line 
Counties highlighted: Jasper, Hampton, Colleton, Barnwell, Bamberg, Orangeburg, Sumter, Lee, 
Darlington, Allendale, Clarendon, Williamsburg, Dillon, Marlboro, Fairfield, McCormick, and 
Marion 
 
Figure 39. White Total Incidence Rates with White Education 
Counties highlighted: Oconee, Pickens, Cherokee, Marlboro, Chester, Bamberg, and Colleton 
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Figure 40. White Early-Stage Incidence Rates with White Education 
Counties highlighted: Pickens, Anderson, Abbeville, Chester, Fairfield, Darlington, Marlboro, 
Dillon, Barnwell, Colleton, and Bamberg 
 
Figure 41. White Late-Stage Incidence Rates with White Education 
Counties highlighted: Oconee, Pickens, Anderson, Laurens, Spartanburg, Cherokee, Union, 
Chester, Saluda, Bamberg, and Colleton 
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Figure 42. White Mortality Rates with White Education 
Counties highlighted: Anderson, Cherokee, Marlboro, Darlington, Marion, and Colleton 
 
Figure 43. White Total Incidence Rates with Poverty 
Counties highlighted: Oconee, Pickens, Cherokee, Marlboro, Bamberg, and Colleton 
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Figure 44. White Early-Stage Incidence Rates with Poverty 
Counties highlighted: Barnwell, Bamberg, Colleton, Clarendon, Darlington, Marlboro, Dillon, 
Abbeville, Fairfield, and Pickens 
 
Figure 45. White Late-Stage Incidence Rates with Poverty 
Counties highlighted: Allendale, Bamberg, Colleton, Laurens, Cherokee, Pickens, and Oconee 
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Figure 46. White Mortality Rates with White Poverty 
Counties highlighted: Colleton, Clarendon, Marion, Darlington, Marlboro, and Cherokee 
 
Figure 47. African-American Total Incidence Rates with African-American Education 
Counties highlighted: Colleton, Bamberg, Williamsburg, Georgetown, Dillon, Marlboro, 
Lancaster, Chester, Fairfield, and Laurens 
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Figure 48. African-American Early-Stage Incidence Rates with African-American Education 
Counties highlighted: Abbeville, Laurens, Chester, Fairfield, Darlington, Williamsburg, 
Georgetown, Colleton, and Bamberg 
 
Figure 49. African-American Late-Stage Incidence Rates with African-American Education 
Counties highlighted: Jasper, Colleton, Bamberg, Barnwell, Williamsburg, Georgetown, 
Fairfield, Chester, Laurens, and Abbeville 
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Figure 50. African-American Mortality Rates with African-American Education 
Counties highlighted: Hampton, Barnwell, Lee, Williamsburg, Dillon, Chester, Fairfield, 
Laurens, Saluda, and Lancaster 
 
Figure 51. African-American Total Incidence Rates with African-American Poverty 
Counties highlighted: Colleton, Bamberg, Orangeburg, Williamsburg, Georgetown, Horry, 
Florence, Dillon, and Marlboro 
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Figure 52. African-American Early-Stage Incidence Rates with African-American Poverty 
Counties highlighted: Charleston, Colleton, Bamberg, Orangeburg, Georgetown, Williamsburg, 
Marion, Florence, and Darlington 
 
Figure 53. African-American Late-Stage Incidence Rates with African-American Poverty 
Counties highlighted: Hampton, Colleton, Barnwell, Bamberg, Orangeburg, Williamsburg, 
Georgetown, Marion, and Horry 
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Figure 54. African-American Mortality Rates with African-American Poverty 
Counties highlighted: Hampton, Barnwell, Williamsburg, Lee, Saluda, and Dillon 
 
Figure 55. Mortality Rates with 2002 Screening Rates 
Counties highlighted with low screening rates and high mortality: McCormick and Saluda 
Counties highlighted with high screening rates and low mortality: Beaufort, Oconee, Union, and 
Lancaster 
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Figure 56. Mortality Rates and Early-Stage Incidence Rates 
Counties highlighted: Allendale, Barnwell, Colleton, Bamberg, Orangeburg, Dorchester, 
Berkeley, Williamsburg, Sumter, Fairfield, Darlington, Marion, and Dillon 
 
Figure 57. Mortality Rates and Late-Stage Incidence Rates 
Counties highlighted: Jasper, Colleton, Dorchester, Berkeley, Williamsburg, Orangeburg, 
Bamberg, Allendale, Barnwell, Lee, Marion, McCormick, Fairfield, and Laurens 
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Figure 58. African-American Education with 2001 Screening Rates 
Counties highlighted: Abbeville, McCormick, Saluda, and Chesterfield 
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